Conference
Oral anticoagulant therapy (OAT) following heart valve replacement (HVR): Comparison of a daily fixed 2.5 mg with a 5 mg, INR adjusted, dose
Authors
Ageno W; Turpie AGG; Steidl L; Codari RL; Ambrosini F; Cattaneo R; Nardo B; Barlocco E; Castelli N; Tarelli G
Pagination
pp. 549-550
Publisher
F K SCHATTAUER VERLAG GMBH
Publication Date
August 1, 1999
Conference proceedings
THROMBOSIS AND HAEMOSTASIS
ISSN
0340-6245